IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
2.350
-0.050 (-2.08%)
At close: Jan 9, 2026, 4:00 PM EST
2.340
-0.010 (-0.43%)
After-hours: Jan 9, 2026, 6:25 PM EST
IN8bio Market Cap
IN8bio has a market cap or net worth of $10.89 million as of January 9, 2026. Its market cap has decreased by -37.39% in one year.
Market Cap
10.89M
Enterprise Value
3.16M
1-Year Change
-37.39%
Ranking
Category
Stock Price
$2.35
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $10.89M, a decrease of -94.19%. That is a compound annual growth rate of -47.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 10.89M | 0.43% |
| Dec 31, 2025 | 10.84M | -41.83% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |